These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Is hormonal therapy still justified in imminent abortion? (author's transl)]. Berle P; Budenz M; Michaelis J Z Geburtshilfe Perinatol; 1980 Oct; 184(5):353-8. PubMed ID: 7197091 [TBL] [Abstract][Full Text] [Related]
3. [The study of the effectiveness of 17-alpha-hydroxyprogesterone capronate in the treatment of threatened abortion]. Kubinyi J; Pilishegyi J Orv Hetil; 1969 Mar; 110(12):654-5. PubMed ID: 4889626 [No Abstract] [Full Text] [Related]
4. [Is there any evidence that the maternal HPL serum-concentration is of prognostic value in cases of threatened abortion? (author's transl)]. Berle P; Behnke K Z Geburtshilfe Perinatol; 1977 Jun; 181(3):211-7. PubMed ID: 888497 [TBL] [Abstract][Full Text] [Related]
6. Double-blind controlled trial of progesterone substitution in threatened abortion. Gerhard I; Gwinner B; Eggert-Kruse W; Runnebaum B Biol Res Pregnancy Perinatol; 1987; 8(1 1ST Half):26-34. PubMed ID: 2437967 [TBL] [Abstract][Full Text] [Related]
7. [Allylestrenol (Gestormon) in the treatment of threatened abortion]. Linhart L; Roztocil A; Pilka D Cesk Gynekol; 1993 Apr; 58(2):71-3. PubMed ID: 8319287 [No Abstract] [Full Text] [Related]
8. [Hormone therapy of spontaneous abortion. Our experience with treatment with Gravibinan]. Drazancić A; Latin V Jugosl Ginekol Opstet; 1978; 18(3-4):325-33. PubMed ID: 757251 [TBL] [Abstract][Full Text] [Related]
9. [Hormonal studies and clinical observations in patients with threatening abortion or premature birth, respectively treated with depot-17-alpha-hydroxyprogesterone-caproate]. Tóth F; Kónya Z Z Geburtshilfe Gynakol; 1971 Oct; 175(2):168-75. PubMed ID: 5118523 [No Abstract] [Full Text] [Related]
10. The impact of dydrogesterone supplementation on hormonal profile and progesterone-induced blocking factor concentrations in women with threatened abortion. Kalinka J; Szekeres-Bartho J Am J Reprod Immunol; 2005 Apr; 53(4):166-71. PubMed ID: 15760377 [TBL] [Abstract][Full Text] [Related]
11. Allylestrenol: three years of experience with Gestanon in threatened abortion and premature labor. Cortés-Prieto J; Bosch AO; Rocha JA Clin Ther; 1980; 3(3):200-8. PubMed ID: 7459930 [TBL] [Abstract][Full Text] [Related]
13. Hormone load tests in the first half of pregnancy--a diagnostic and therapeutic approach. Gerhard I; Runnebaum B Biol Res Pregnancy Perinatol; 1984; 5(4):157-73. PubMed ID: 6084523 [TBL] [Abstract][Full Text] [Related]
15. [Diagnosis, treatment and prognosis of threatened abortion]. Wilken H; Schrodt U; El-Zoobi A Zentralbl Gynakol; 1976; 98(10):577-86. PubMed ID: 785873 [TBL] [Abstract][Full Text] [Related]
16. [The incidence of congenital abnormalities following gestagen administration in early pregnancy (author's transl)]. Schneider WH; Philipp K; Schmid R Wien Klin Wochenschr; 1981 Dec; 93(23):711-2. PubMed ID: 7342466 [TBL] [Abstract][Full Text] [Related]
17. [On the use of fenoterolhydrobromide in the treatment of imminent abortion (author's transl)]. Ruppin E; Eberhard F; Chelius HH Geburtshilfe Frauenheilkd; 1978 Jun; 38(6):461-7. PubMed ID: 669234 [TBL] [Abstract][Full Text] [Related]
18. [Effect of prolonged use of progesterone compounds on fetal weight]. Hertz P; Sani L Akush Ginekol (Mosk); 1980 Aug; (8):24-5. PubMed ID: 7416389 [No Abstract] [Full Text] [Related]
19. [Hormonal supervision of threatened abortion. diagnosis and therapy (author's transl)]. Knapstein P MMW Munch Med Wochenschr; 1980 Jun; 122(26):970-2. PubMed ID: 6775195 [TBL] [Abstract][Full Text] [Related]
20. [Letter: Are progestational agents indicated in threatened abortion?]. Wildschut J Ned Tijdschr Geneeskd; 1976 Feb; 120(7):296-7. PubMed ID: 1250470 [No Abstract] [Full Text] [Related] [Next] [New Search]